Objective Several studies have found inverse associations between breastfeeding and ovarian cancer occurrence but there are inconsistencies. The relationship with breastfeeding duration is unclear, and it is uncertain whether the association varies according to histological subtype of ovarian cancer. We sought to clarify these issues. Methods Parous women who participated in an Australiawide population-based case-control study of epithelial ovarian cancer between 2001 and 2005 (1,092 cases and 1,288 controls) completed a reproductive/lifestyle questionnaire. Logistic regression was used to calculate odds ratios and 95% confidence intervals to investigate relations between breastfeeding and ovarian cancer. Results We found a strong inverse association between total duration of breastfeeding (all episodes combined) and ovarian cancer occurrence (OR = 0.986, 95% CI 0.978-0.994 per month of breastfeeding) that appeared to be independent of parity. However, individual episodes of lactation beyond 12 months conferred no appreciable additional benefit. The relation with breastfeeding appeared to vary by histological subtype such that we saw no association between duration of breastfeeding and borderline serous cancers or mucinous cancers, but inverse associations for the other subtypes, although these were not always statistically significant. Conclusions A long total duration of breastfeeding appears to be associated with a substantial reduction in the overall risk of ovarian cancer, independent of the decrease in risk due to childbirth, but this may vary according to histological subtype.
Introduction
According to two of the prevailing theories, epithelial ovarian cancer may be caused by the recurrent breakdown and repair of the ovarian epithelium resulting from long periods of undisrupted ovulation [1] , or it may be due to the proliferative effects of high levels of circulating gonadotrophins on the ovarian epithelium [2] . As breastfeeding generally induces a state of relative quiescence in women's ovaries by suppressing the release of luteinising hormone (LH) and thereby preventing ovulation [3] , according to either of these theories, prolonged breastfeeding would be expected to decrease the risk of ovarian cancer.
The evidence for a relationship between breastfeeding and epithelial ovarian cancer has, however, been somewhat inconsistent (reviewed by Danforth et al. [4] and Riman et al. [5] ), and the World Cancer Research Fund concluded in their 2007 report that there is only limited evidence to suggest that lactation protects against ovarian cancer [6] . While most studies have suggested that breastfeeding decreases the risk of ovarian cancer, reported effects have generally been small and often not statistically significant [6] . Furthermore, it has been suggested by some that the risk reduction after breastfeeding cannot be fully separated from the reduction in risk due to childbirth [7] . Some studies have also found that the effect of breastfeeding might vary by the histological subtype of epithelial ovarian cancer although, again, findings have been inconsistent. For example, the results of some studies have indicated that breastfeeding may decrease the risk of endometrioid ovarian cancer to a greater extent than other subtypes [4, 8, 9] . Other studies have found that the risk of mucinous ovarian cancers is not influenced by breastfeeding [10] [11] [12] while others have found no differences between subtypes [7, 13, 14] . Most of these subtype-specific analyses relied on very small numbers of women with the non-serous subtypes of ovarian cancer, perhaps explaining the heterogeneous findings.
We have used data from a large Australian case-control study to further investigate the relation between breastfeeding and ovarian cancer and to assess variation by histological subtype of ovarian cancer. As the suppressive effect of breastfeeding on ovulation diminishes with increasing duration of individual episodes of breastfeeding [15] , we were also interested to explore the association between ovarian cancer and prolonged episodes of lactation.
Materials and methods

Study participants
The Australian Ovarian Cancer Study was an Australiawide population-based case-control study of epithelial ovarian cancer, whose design and recruitment details have been reported previously [16, 17] . Eligible cases were women aged 18-79 years living in Australia with histologically confirmed epithelial ovarian, fallopian tube or primary peritoneal cancer newly diagnosed between January 2002 and June 2005. Cases were recruited prior to surgery (where possible) by nurses who liaised with the treatment clinics, physicians and state cancer registries throughout Australia. Of 3,550 women identified with a clinically suspected diagnosis of ovarian cancer, 805 were not approached due to sickness, death, clinician refusal or an inability to complete the study documents in English. Of the remaining 2,745 women, 2,319 (85%) agreed to take part. After surgery, a further 608 women were excluded because their final histological diagnosis was a benign, non-epithelial or metastatic tumour, a further 25 because their cancer was first diagnosed before the start of the study period and 1 because she was not an Australian resident at the time of her initial diagnosis. Two researchers independently abstracted information on tumour site, histological subtype and tumour behaviour (invasive vs. borderline) from the diagnostic histopathology reports. Discrepancies were resolved by consensus. To check the quality of the abstracted data, the pathology reports and full set of diagnostic slides for a sample of 200 women were reviewed by a gynaecologic pathologist; agreement with the abstracted data was [95% for tumour subtype and site and 99% for tumour behaviour. Of the 1,685 patients who were known to be eligible and agreed to participate in the study, 1,591 (94%) returned a questionnaire.
Controls were randomly selected from the national electoral roll (enrolment is compulsory) and were frequency matched by age (in 5-year age bands) and state of residence to the case group. Of the 3,613 women contacted and invited to participate, 11 women had died after initial contact, while 160 women were excluded due to illness or language difficulties. Of the remaining 3,442 women, 1,613 agreed to participate and returned a questionnaire (47% 
Data collection
Information was collected using a self-administered questionnaire that included questions about demographical, medical, hormonal, reproductive, family history and other potential risk factors. Exposures were assessed prior to a reference date, defined as 1 year before the date of diagnosis (or date of first approach for controls) because it was felt that more recent exposures in cases could be influenced by the presence of subclinical disease. One section of the questionnaire sought information about pregnancy history, including the outcome of each pregnancy and, where appropriate, the length of time each child was breastfed.
Data analysis
Only parous women were included in the analyses, which were conducted by means of conditional logistic regression within strata of age in single years. Peritoneal cancers (n = 114) were excluded because a previous analysis found that the effects of breastfeeding differed substantially in women with peritoneal cancers [18] , but women with fallopian tube cancer (n = 40) were included.
Three measures of breastfeeding were initially adopted: an indicator of whether breastfeeding was initiated (''ever breastfed''); total months of breastfeeding (''duration''); and duration grouped into six categories as follows: Never, 0.1-6, 6.1-18, 18.1-30, 30.1-42 and [42 months. This grouping was used so that the midpoints of the categories beyond the second are 1 year, 2 years etc. This procedure was used to counter the presence of a certain amount of digit preference. Duration of breastfeeding is highly correlated with parity, so we adopted two approaches to control for parity. We first used multiple logistic regression analysis with a term for parity (categorised 1, 2, 3, 4 and C5) in the model. For the analysis of breastfeeding duration only, we also conducted multiple logistic regressions within four strata of parity (1, 2, 3, 4 or more) and aggregated the resulting logistic coefficient across these strata with inverse variance weights. Since the aggregated odds ratio was almost identical to that from the logistic analysis with parity included as a covariate, only the stratum-specific odds ratios and the adjusted results from the logistic model are reported. We also investigated the association between average months of breastfeeding per birth and ovarian cancer by using a variable derived by dividing the total duration of breastfeeding by the number of births.
Other covariates included in the models were age at first full-term pregnancy (\20 years, C20 years), duration of oral contraceptive use in months, menopausal status, smoking (never, current and ex-smoker), prior tubal ligation, prior hysterectomy, alcohol consumption (never, 1-6 and [6 standard drinks per week), highest education level attained (high school only, technical qualification or diploma, university) and family history of ovarian or breast cancer. Age at first birth and age at last birth were highly correlated in our data, and using age at last rather than age at first birth made no appreciable difference to estimates. No covariate had more than a handful of missing values (all \1%) in this subgroup of women (parous and with usable breastfeeding histories), and these were assigned to the unexposed or lowest exposure category. Where the menopausal status of a woman was not clear (for example, if the woman had had a hysterectomy or was taking hormones around the time of menopause), we assigned this based on average age at menopause of study participants who reported a natural menopause. As for other studies, we found the average age at menopause varied by smoking status; thus, for smokers, we used age 48 years as the cut off, and for non-smokers we used age 50 years.
We also investigated the possibility of effect modification by hormonal contraceptive use and estimated odds ratios for ever breastfeeding and duration of breastfeeding by histological subtype using the same statistical models. Invasive and borderline mucinous cancers were considered together in subtype-specific analyses as it is likely that invasive mucinous cancers arise from borderline mucinous cancers, while invasive and borderline serous cancers were considered separately as evidence suggests that these are separate neoplastic entities [19] .
We also considered whether longer individual episodes of lactation had a different association with ovarian cancer compared with shorter episodes of lactation. To this end, the episode of lactation following each full-term pregnancy was categorised as of zero, 0.1-6, 6.1-12 and [12 months. Individual episodes of lactation longer than 2 years were uncommon (\1%). Few women had parity greater than five (7% of eligible pregnancies), thus these births were excluded; pregnancies ending in a stillbirth were included in the reference category of zero breastfeeding. As expected, the durations of individual episodes of breastfeeding within an individual woman were fairly highly correlated, less so for lactations further apart in birth order. Inter-episode correlation coefficients of the logarithm of the odds ratio (log OR) were estimated within strata of parity and aggregated across these strata for the three durations of lactation length (0.1-6, 6.1-12 and [12 months) and for adjacent breastfeeding episodes, episodes two apart in birth order and episodes three or four apart in birth order. These were then used first, to aggregate log ORs individually across breastfeeding episodes using inverse variance-covariance matrices as weights within each parity class, and then to aggregate across parity classes, again using inverse weights. We ignored the correlations between the ORs for the three lactation length categories. Sensitivity analyses with different correlation structures made little difference to the resulting ORs but suggested that the estimated confidence intervals should be treated as indicative only.
Results
Among the cases, there were 134 women with peritoneal cancer who were excluded, leaving 1,457 women for analysis. There were 1,159 women (80%) who reported at least one full-term pregnancy, of whom 1,092 (94%) provided breastfeeding details; among the controls, the corresponding figures were 1,328 (89%) and 1,288 (97%). Selected characteristics of the women are summarised in Table 1 . As expected, controls had higher numbers of births and longer durations of hormonal contraceptive use but were less likely to have a family history of breast or ovarian cancer than cases. Control women were on average a little younger than case women and a greater proportion of controls were pre-menopausal compared with cases. Odds ratios for ovarian cancer by categories of increasing duration of breastfeeding (Table 2) 
linear trend; all further results are presented in terms of two measures, ever/never breastfed and per month of total breastfeeding. In these data, there was a strong inverse association between breastfeeding and ovarian cancer, with an estimated relative risk of 0.77 (95% CI 0.61-0.96) among parous women who had ever breastfed compared with parous women who never breastfed equating to an average 1.4% (95% CI 0.6-2.2%) decrease in risk per month of breastfeeding (Table 2 ). This reduction was independent of parity ( Table 3) . As in a previous Australian study [20] , the effects of both ever breastfeeding and duration of breastfeeding were weaker among women with post-menopausal ovarian cancer (OR = 0.68, 95% CI 0.42-1.12 versus 0.81, 95% CI 0.63-1.05 for ever breastfed and OR per month = 0.980, 95% CI 0.967-0.994 versus 0.988, 95% CI 0.979-0.998 for pre-and post-menopausal women, respectively) but the difference is consistent with chance, as is clear from the bounds of the confidence intervals. These estimates did not change appreciably when the models were additionally adjusted for use of hormone replacement therapy.
There was no evidence that the effect of breastfeeding was modified by women's use of hormonal contraceptives either when all women were considered (OR = 0.988 and 0.985 per month of breastfeeding for never-and ever-users of hormonal contraceptives, respectively) or when premenopausal and post-menopausal women were considered separately (data not shown).
In the analysis by subtype presented in Table 4 , only the invasive serous category was of more than modest size, and all confidence intervals were wide. However, with the exception of borderline serous cancers and mucinous cancers, the results were broadly consistent with the overall findings.
For individual episodes of lactation of 0.1-6, 6.1-12 and [12 months, the estimated ORs (and their approximate 95% CIs) were 0.76 (0.64-0.90), 0.59 (0.48-0.73) and 0.61 (0.43-0.82), respectively, compared to parous women who never breastfed, and controlling only for parity. Although allowing for other covariates, were this practicable, might alter the absolute values of the OR, it is unlikely that the overall pattern of the results would change, particularly since adjusting the main results for parity only altered each estimate by under 4%.
Discussion
Overall, our results showed a strong inverse association between any breastfeeding, duration of breastfeeding and epithelial ovarian cancer occurrence that appeared to be independent of parity. However, for individual episodes of lactation, breastfeeding beyond 12 months did not appear to confer additional benefit. We also found some evidence that the effect of breastfeeding differed between histological subtypes. Serous borderline cancers did not appear to have any relation with lactation and, although our estimate for ever having breastfed was consistent with a reduction in risk of mucinous ovarian cancers, there was no evidence that the occurrence of these cancers was related to duration (21) 308 (24) of breastfeeding. Our results also suggested a weaker effect of breastfeeding on ovarian cancer risk among postmenopausal women. Our estimate of a reduction in risk of 1.4% per month of lactation is consistent with our earlier study of a separate series of cases and controls [20] and with a recent estimate from a prospective study in the United States, albeit with less than 400 ovarian cancer cases, which reported a hazard ratio of 0.98 per month of breastfeeding [4] . A pooled analysis of five population-based case-control studies reported a significant 1% reduction per month of breastfeeding [21] , while a later Canadian populationbased study reported a significant risk reduction of 5% per month of average lactation per pregnancy [10] . Most other studies referenced in a recent paper [4] also showed a statistically significant or non-significant inverse relation between breastfeeding and ovarian cancer after control for parity, although they did not provide an estimate of reduction in risk per unit time. However, one hospitalbased case-control study conducted in Italy found that the apparent risk-reducing effect of breastfeeding was entirely accounted for by parity [7] . Only one report, from a British hospital-based case-control study, found an increased risk of epithelial ovarian cancer associated with prolonged breastfeeding, but with a non-significant test for trend [22] . It may be that the hospital controls used in these studies were not representative of the general population with respect to their breastfeeding practises.
Strengths of the current study were its large size, population base and detailed information on important exposures. A weakness was its low participation rate among controls (47%). This would be of concern in relation to our estimates of relative risk for the various measures of breastfeeding if the parous women who did and who did not return questionnaires had different distributions of breastfeeding, and in particular if they breastfed less. In the 2001 Australia-wide National Health Survey (response rate 111 (4) 195 ( in excess of 90%) [23], parous women under 65 years of age were asked whether they had ever breastfed. After adjustment to the observed age distribution among our controls, the proportion of women in the National Health Survey reporting having ever breastfed was 82% (N. Pandeya, written communication, November 2008) compared to 83% among the control women aged under 65 years of age in our study. Similarly, the age-standardised distribution of parity in the NHS was almost identical to that among the control women in our study. This suggests that bias in selecting controls was unlikely to have artificially inflated to any appreciable extent the inverse association of breastfeeding with epithelial ovarian cancer that we found. Overall, we observed the effects of breastfeeding to be similar for the different histological subtypes of ovarian cancer with the exception of borderline serous tumours, for which the protective effect of breastfeeding was not apparent; and mucinous cancers, for which there was no evidence of a dose-response effect. Among previous studies that have considered histological subtypes, results have been very variable, probably because of the small sample sizes available for analysis [7, [9] [10] [11] [12] [13] [14] . Large pooled or meta-analyses are required to conclusively answer this question, but a different relationship with mucinous cancers is plausible, given that they appear to have different risk factors [24, 25] and most likely arise in different ways to other ovarian cancer subtypes [19, 26] . Borderline serous cancers are also thought to arise via a different sequence from most invasive serous cancers [19] and thus different risk factors might be expected for this subtype also.
Although the difference was consistent with chance, our results suggest that, in keeping with the findings of other studies [4, 20, 27] , the apparent protective effect of breastfeeding is slightly weaker in post-menopausal than pre-menopausal women. It is possible that this reflects differences in breastfeeding practices between the younger and the older women in our study (e.g., the intensity of breastfeeding or the duration of exclusive breastfeeding), but we did not request this information from participants so could not formally test this. Another possible explanation is that in general, the pre-menopausal women would have had more opportunity to have taken progesterone-only contraceptives during lactation than the post-menopausal women. However, neither adjustment for nor stratification by hormonal contraceptive use altered our findings substantially, although we were unable to look specifically at contraceptive use during lactation. An alternate explanation might be that the effect of breastfeeding diminishes over time and thus appears stronger in pre-menopausal than post-menopausal women because their breastfeeding occurred more recently. However, time since last breastfeeding episode is highly correlated with time since last pregnancy, and we could not separate these effects and therefore have not reported them here.
Breastfeeding has a number of physiological effects that may account for the protective effect against ovarian cancer that we have found. In most women, exclusive breastfeeding causes suppression of gonadotrophins (particularly LH), resulting in depressed production of plasma estradiol (levels consistent with those seen in post-menopausal women), anovulation and amenorrhoea [3] . In the absence of ovulation, progesterone levels also remain low. The four most commonly cited theories of ovarian carcinogenesis invoke incessant ovulation [1] ; elevated gonadotrophins and estrogens [2] ; the retrograde passage of contaminants to the ovary (mostly via retrograde menstruation) [28] [29] [30] ; and androgen excess and/or progesterone insufficiency [31] as potential causal mechanisms. Thus, according to the first three of these theories, breastfeeding would be expected to lower ovarian cancer risk as long as ovulatory cycles were suppressed. For each episode of breastfeeding, the duration of suppression of ovulation and menstruation depends, in part, upon intensity of breastfeeding [3, 15] . However, in most women who breastfeed for an extended period of time, ovulatory cycles return prior to the cessation of breastfeeding, often around the time of the introduction of supplementary feeds to the infant [15] . If the protective effects of breastfeeding were due to the suppression of ovulatory cycles, then the risk reduction associated with individual episodes of lactation should plateau at longer durations. Indeed, our results support this: an episode of lactation lasting 6-12 months reduced risk more than one lasting for less than 6 months, but feeding beyond 12 months appeared to provide no additional protection. Variations in breastfeeding practises and timing of the introduction of supplementary feeds may explain some of the variability in results across previous studies of breastfeeding and ovarian cancer. Investigations of the relationship between ovarian cancer and factors such as breastfeeding intensity and the duration of lactational amenorrhoea may further inform our understanding of the mechanisms and magnitude of protection afforded by breastfeeding.
In conclusion, we have found that breastfeeding is associated with a substantial reduction in the risk of ovarian cancer, independent of the reduction in risk due to childbirth. These results, building on those from previous studies, suggest that this reduction in risk of ovarian cancer should be promoted to women of reproductive age as one of the long-term maternal benefits of prolonged breastfeeding.
